Akers AY, Newmann SJ, Smith JS (2007) Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 31:157–181

Article  PubMed  Google Scholar 

Bakels HS, Roos RAC, van Roon-Mom WMC, de Bot ST (2022) Juvenile-onset Huntington Disease Pathophysiology and Neurodevelopment: a review. Mov Disord 37:16–24

Article  PubMed  Google Scholar 

Bolzan G, Müller Eyng ME, Leotti VB, Saraiva-Pereira ML, Jardim LB (2024) Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease. Cortex 171:370–382

Article  PubMed  Google Scholar 

Christopher AS, McCormick D, Woolhandler S, Himmelstein DU, Bor DH, Wilper AP (2016) Access to care and chronic disease outcomes among Medicaid-insured persons versus the uninsured. Am J Public Health 106:63–69

Article  PubMed  PubMed Central  Google Scholar 

Coarelli G, Wirth T, Tranchant C, Koenig M, Durr A, Anheim M (2023) The inherited cerebellar ataxias: an update. J Neurol 270(1):208–222

Article  PubMed  Google Scholar 

de Mattos EP, Leotti VB, Soong BW et al (2019) Age at onset prediction in spinocerebellar ataxia type 3 changes according to population of origin. Eur J Neurol 26:113–120

Article  PubMed  Google Scholar 

Diretrizes para Atenção (2014) Integral às Pessoas com Doenças Raras no Sistema Único de Saúde–SUS, Portaria n° 199: Ministério da Saúde. Available in https://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_atencao_integral_pessoa_doencas_raras_SUS.pdf (Portuguese) January 30

Dos Santos Pinheiro J, Sena LS, Donis KC, Furtado GV, Saraiva-Pereira ML, Jardim LB (2023) Diagnostic Delay of Hereditary ataxias in Brazil: the case of Machado-Joseph Disease. Cerebellum 22:348–354

Article  CAS  PubMed  Google Scholar 

Dubiela ALF [Da rede básica de saúde a um serviço de referência: avaliação dos encaminhamentos ao atendimento especializado em genética médica] (Portuguese) Available in https://www.sbgm.org.br/Uploads/M5T3KBFmI2_05_07_2021-15_21_49_26. pdf Abstract, XXXII Congresso Brasileiro de Genética Médica, April 30 to May 01, 2021

Félix TM, de Oliveira BM, Artifon M et al (2022) Epidemiology of rare diseases in Brazil: protocol of the Brazilian rare diseases Network (RARAS-BRDN). Orphanet J Rare Dis 17:8

Article  Google Scholar 

Ghosh R, Tabrizi SJ (2018) Clinical features of Huntington’s Disease. Adv Exp Med Biol 1049:1–28

Article  CAS  PubMed  Google Scholar 

Indelicato E, Nachbauer W, Eigentler A et al (2020) Onset features and time to diagnosis in Friedreich’s Ataxia. Orphanet J Rare Dis 15:198

Article  PubMed  PubMed Central  Google Scholar 

Jardim LB (2024) Delay in Healthcare of Genetic Movement Disorders. OSF. June 25, Dataset https://doi.org/10.17605/OSF.IO/P5324

Langbehn DR, Hayden MR, Paulsen JS (2010) CAG-Repeat length and the age of Onset in Huntington Disease (HD) a review and validation study of statistical approaches. Am J Med Genet Part B 153:397–408

Article  Google Scholar 

Machado DS, Viana CF, Pedroso JL et al (2024) Prevalence and Diagnostic Journey of Friedreich’s Ataxia in the State of São Paulo, Brazil. Cerebellum Mar 23. https://doi.org/10.1007/s12311-024-01687-w. Online ahead of print

Martinez ARM, Ribeiro MC, Lima FD, Martins CR Jr, Martins MP, Nucci A, França MC Jr (2019) Misdiagnosis and diagnostic delay in non-paraneoplastic sensory neuronopathies. Arq Neuropsiquiatr 77:451–455

Article  PubMed  Google Scholar 

Perlow HK, Ramey SJ, Silver B et al (2018) Assessment of Oropharyngeal and Laryngeal Cancer Treatment Delay in a private and Safety Net Hospital System. Otolaryngology–Head Neck Surg 159:484–493

Article  Google Scholar 

Ratnapradipa KL, Jadhav S, Kabayundo J, Wang H, Smith LC (2023) Factors associated with delaying medical care: cross-sectional study of Nebraska adults. BMC Health Serv Res 4(1):118

Article  Google Scholar 

Reetz K, Dogan I, Costa AS et al (2015) Biological and clinical characteristics of the European Friedreich’s Ataxia Consortium for Translational studies (EFACTS) cohort: a cross-sectional analysis of baseline data. Lancet Neurol 14:174–182

Article  PubMed  Google Scholar 

Schuler-Faccini L, Osorio CM, Romariz F, Paneque M, Sequeiros J, Jardim LB (2014) Genetic counseling and presymptomatic testing programs for Machado-Joseph Disease: lessons from Brazil and Portugal. Genet Mol Biol 37(1 Suppl):263–270

Article  PubMed  Google Scholar 

Warner JH, Long JD, Mills JA, Langbehn DR, Ware J, Mohan A, Sampaio C (2020) Standardizing the CAP Score in Huntington’s Disease I: Predicting Age-at-Onset. J Huntingtons Dis 2022; 11:153–171

Weissman JS, Stern R, Fielding SL, Epstein AM (1991) Delayed access to health care: risk factors, reasons, and consequences. Ann Intern Med 114:325–331

Article  CAS  PubMed  Google Scholar